| An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer SV Lindskrog, F Prip, P Lamy, A Taber, CS Groeneveld, ... Nature communications 12 (1), 2301, 2021 | 200 | 2021 |
| The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes C Pfannstiel, PL Strissel, KB Chiappinelli, D Sikic, S Wach, RM Wirtz, ... Cancer immunology research 7 (6), 923-938, 2019 | 148 | 2019 |
| Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first … M Eckstein, P Erben, MC Kriegmair, TS Worst, CA Weiß, RM Wirtz, ... European journal of cancer 106, 234-243, 2019 | 98 | 2019 |
| Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant … M Eckstein, P Strissel, R Strick, V Weyerer, R Wirtz, C Pfannstiel, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 52 | 2020 |
| Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype U Zinnall, V Weyerer, E Compérat, P Camparo, NT Gaisa, ... Human pathology 80, 55-64, 2018 | 44 | 2018 |
| Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma V Weyerer, R Weisser, EA Moskalev, F Haller, R Stoehr, M Eckstein, ... Histopathology 75 (6), 865-875, 2019 | 35 | 2019 |
| The genitourinary pathology society update on classification and grading of flat and papillary urothelial neoplasia with new reporting recommendations and approach to lesions … MB Amin, E Comperat, JI Epstein, LD True, D Hansel, GP Paner, ... Advances in anatomic pathology 28 (4), 179-195, 2021 | 33 | 2021 |
| The genitourinary pathology society update on classification of variant histologies, T1 substaging, molecular taxonomy, and immunotherapy and PD-L1 testing implications of … E Compérat, MB Amin, JI Epstein, DE Hansel, G Paner, H Al-Ahmadie, ... Advances in anatomic pathology 28 (4), 196-208, 2021 | 32 | 2021 |
| Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling A Wullweber, R Strick, F Lange, D Sikic, H Taubert, S Wach, B Wullich, ... Cancer research 81 (6), 1552-1566, 2021 | 32 | 2021 |
| Dual functional states of R406W-desmin assembly complexes cause cardiomyopathy with severe intercalated disc derangement in humans and in knock-in mice H Herrmann, E Cabet, NR Chevalier, J Moosmann, D Schultheis, J Haas, ... Circulation 142 (22), 2155-2171, 2020 | 32 | 2020 |
| Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation R Morsch, M Rose, A Maurer, MA Cassataro, T Braunschweig, R Knüchel, ... BMC cancer 20, 1-10, 2020 | 30 | 2020 |
| Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy … V Weyerer, R Stoehr, S Bertz, F Lange, CI Geppert, S Wach, H Taubert, ... World Journal of Urology 39, 4011-4019, 2021 | 29 | 2021 |
| Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years V Weyerer, R Schneckenpointner, T Filbeck, M Burger, F Hofstaedter, ... Journal of Cancer 8 (3), 323, 2017 | 29 | 2017 |
| Sinonasal papillomas: A single centre experience on 137 cases with emphasis on malignant transformation and EGFR/KRAS status in “carcinoma ex papilloma” S Maisch, SK Mueller, M Traxdorf, V Weyerer, R Stoehr, H Iro, A Hartmann, ... Annals of Diagnostic Pathology 46, 151504, 2020 | 27 | 2020 |
| Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary … V Weyerer, M Eckstein, E Compérat, H Juette, NT Gaisa, Y Allory, R Stöhr, ... Cancers 12 (3), 763, 2020 | 27 | 2020 |
| CCL2 expression in tumor cells and tumor-infiltrating immune cells shows divergent prognostic potential for bladder cancer patients depending on lymph node stage M Eckstein, E Epple, R Jung, K Weigelt, V Lieb, D Sikic, R Stöhr, ... Cancers 12 (5), 1253, 2020 | 24 | 2020 |
| Analysis of CXCL9, PD1 and PD-L1 mRNA in stage T1 non-muscle invasive bladder cancer and their association with prognosis J Kubon, D Sikic, M Eckstein, V Weyerer, R Stöhr, A Neumann, B Keck, ... Cancers 12 (10), 2794, 2020 | 18 | 2020 |
| Endogenous retroviral–K envelope is a novel tumor antigen and prognostic indicator of renal cell carcinoma V Weyerer, PL Strissel, C Stöhr, M Eckstein, S Wach, H Taubert, L Brandl, ... Frontiers in Oncology 11, 657187, 2021 | 16 | 2021 |
| TERT Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers V Weyerer, M Eckstein, PL Strissel, A Wullweber, F Lange, L Tögel, ... Genes 12 (2), 230, 2021 | 16 | 2021 |
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms M Schmiester, A Dolnik, U Kornak, B Pfitzner, M Hummel, D Treue, ... The Journal of Pathology: Clinical Research 7 (1), 3-9, 2021 | 16 | 2021 |
